CHEN, Ruilin. Semaglutide as a Novel Therapeutic Agent for Obesity and Type 2 Diabetes. Transactions on Materials, Biotechnology and Life Sciences, [S. l.], v. 8, p. 454–459, 2025. DOI: 10.62051/5008za94. Disponível em: https://tmbls.org/index.php/ojs/article/view/73. Acesso em: 16 may. 2026.